HORMONE AND METABOLIC RESEARCH
Scope & Guideline
Connecting Hormonal Dynamics to Metabolic Health
Introduction
Aims and Scopes
- Endocrine Disorders and Hormonal Regulation:
The journal extensively covers research related to various endocrine disorders, including thyroid disorders, adrenal insufficiencies, and metabolic syndromes. It aims to elucidate the role of hormones in these conditions and their management. - Metabolic Syndrome and Related Complications:
Research on metabolic syndrome, including its biochemical markers, risk factors, and associations with other diseases like diabetes and cardiovascular conditions, is a core focus. The journal emphasizes studies that explore the pathophysiological mechanisms underlying these conditions. - Innovative Therapeutic Approaches:
The journal encourages research that investigates new therapeutic strategies and pharmacological interventions for metabolic and endocrine disorders, including the use of novel drugs and treatment protocols. - Molecular Mechanisms and Biomarkers:
The journal publishes studies that delve into the molecular pathways involved in hormone regulation and metabolism, identifying potential biomarkers for early diagnosis and prognosis of endocrine and metabolic diseases. - Clinical Implications and Public Health:
There is a strong emphasis on clinical research that translates findings into practical applications, addressing public health concerns related to metabolic disorders, including obesity, diabetes, and cardiovascular diseases.
Trending and Emerging
- Metabolic Effects of COVID-19:
Recent articles have focused on the interplay between COVID-19 and metabolic disorders, highlighting how the pandemic has affected patients with pre-existing conditions and the implications for treatment and management. - Role of Gut Microbiome in Metabolism:
There is an increasing interest in exploring how the gut microbiome influences hormonal regulation and metabolic health, suggesting a shift towards a more integrative approach in understanding metabolism. - Personalized Medicine Approaches:
Emerging research emphasizes personalized medicine in treating endocrine and metabolic disorders, including the use of genetic and phenotypic information to tailor treatment strategies. - Molecular Pathways in Hormonal Regulation:
There is a growing trend in investigating the molecular pathways that govern hormonal actions and their impact on various metabolic processes, including the utilization of advanced technologies like metabolomics and genomics. - Integration of Digital Health Technologies:
The incorporation of digital health technologies and telemedicine into the management of metabolic disorders is becoming a prominent theme, reflecting a broader shift in healthcare delivery systems.
Declining or Waning
- Traditional Hormone Replacement Therapies:
Research related to conventional hormone replacement therapies has seen a decline, possibly due to the emergence of newer, more targeted therapies that offer improved outcomes and safety profiles. - Older Metabolic Syndrome Definitions:
The journal has published fewer studies focused on outdated definitions and diagnostic criteria for metabolic syndrome, as the field moves towards more refined and clinically relevant classifications. - Single Hormone Studies:
There has been a noticeable decrease in publications that focus solely on the effects of individual hormones without considering their interactions within the broader endocrine system and metabolic pathways. - Animal Model Studies:
Research utilizing traditional animal models for metabolic and endocrine diseases is less prevalent, possibly due to a shift towards human clinical trials and translational research that better reflects human physiology. - Epidemiological Studies with Limited Scope:
There is a waning interest in epidemiological studies that lack comprehensive data or fail to address broader implications of findings within the context of public health and clinical practice.
Similar Journals
Journal of the Endocrine Society
Advancing endocrinology, one discovery at a time.Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.
Frontiers in Endocrinology
Pioneering Research in Diabetes and Endocrine HealthFrontiers in Endocrinology, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the advancement of research in the fields of endocrinology, diabetes, and metabolism. Established in 2010, this journal has consistently demonstrated its academic excellence, achieving a prominent Q1 quartile ranking in its category as of 2023, and a commendable Scopus rank of #96 out of 244, placing it within the 60th percentile. The journal is committed to disseminating high-quality research that encompasses a wide range of topics within endocrinology, catering to the needs of a diverse audience that includes researchers, medical professionals, and students alike. With the critical goal of fostering knowledge-sharing and collaboration within the scientific community, Frontiers in Endocrinology is an invaluable resource for anyone looking to stay updated on the latest advancements and insights in endocrinology. It operates under a robust open-access model, ensuring that groundbreaking research is accessible to all, thereby driving innovation and progress in this essential field.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
Driving discoveries in the dynamic world of endocrinology.BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM is a leading academic journal published by Elsevier that focuses on the dynamic field of endocrinology and metabolism. With an impressive impact factor reflected in its Q1 ranking in both endocrinology and endocrinology, diabetes, and metabolism for 2023, this journal is essential for researchers, healthcare professionals, and students seeking to stay abreast of the most significant developments in clinical practice and research. Covering a wide range of topics within the scope of endocrinology, the journal provides a platform for innovative research, comprehensive reviews, and insightful case studies, all aimed at enhancing patient care and advancing the field. With robust rankings, including a position of 22nd out of 244 in Endocrinology and a 90th percentile ranking in Biochemistry, Genetics, and Molecular Biology, this journal is recognized for its scholarly contribution and relevance. As an open-access journal, it ensures that valuable research is accessible to a global audience, advancing knowledge and clinical practice in endocrinology.
Revista Portuguesa de Endocrinologia Diabetes e Metabolismo
Enhancing understanding of metabolic disorders.Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.
Therapeutic Advances in Endocrinology and Metabolism
Advancing the frontiers of endocrine health.Therapeutic Advances in Endocrinology and Metabolism is a premier open-access journal published by SAGE Publications Ltd that has established itself as a leading platform for research in the field of endocrinology, diabetes, and metabolism. With a commitment to disseminating high-quality research, the journal aims to advance our understanding of therapeutic interventions and innovations in the management of endocrine disorders. Since its inception in 2010, it has garnered a strong reputation, attaining a Q1 quartile ranking in 2023 in its category and boasting a respectable Scopus rank of #53 out of 244, positioning it within the 78th percentile. As an open-access journal since 2019, Therapeutic Advances in Endocrinology and Metabolism ensures that valuable research findings are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and students alike. The journal's multifaceted objectives encompass the publication of original research, reviews, and clinical studies that contribute to the evolving dialogue surrounding endocrine health. By delivering timely and robust content, it serves as an indispensable resource for those striving to make significant contributions to this vital area of medical science.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Elevating Clinical Standards Through Rigorous ResearchJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, published by the Endocrine Society, stands as a premier academic journal within the field of endocrinology, diabetes, and metabolism. With a legacy spanning from 1941 to 2024, this journal is distinguished by its significant impact factor, ranking in the Q1 category across multiple related disciplines including biochemistry, clinical biochemistry, and medicine. This esteemed journal, ISSN 0021-972X and E-ISSN 1945-7197, is backed by rigorous peer review, ensuring the publication of high-quality research that contributes to the advancement of clinical practices and scientific knowledge. With a commendable Scopus ranking, positioned in the top percentile of multiple categories, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM serves as an essential resource for researchers, professionals, and students who seek to stay informed about the latest findings and innovations in endocrine research. The journal enriches the existing body of knowledge and fosters discussion among scholars and practitioners alike, solidifying its crucial role in the ongoing discourse in endocrinology and metabolic health.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
Bridging Research and Clinical Practice in Child HealthThe JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Navigating the complexities of endocrine and metabolic health.REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.
International Journal of Endocrinology and Metabolism
Elevating Knowledge in Endocrine ScienceThe International Journal of Endocrinology and Metabolism is a leading peer-reviewed publication dedicated to advancing knowledge and research in the fields of endocrinology, diabetes, and metabolism. Published by BRIEFLAND in the Netherlands, this journal features original research, comprehensive reviews, and insightful clinical studies that explore the multifaceted aspects of hormonal disorders and metabolic conditions. With an impact factor that places it in the Q3 quartile category for 2023, the journal serves as a critical resource for academics and practitioners aiming to stay at the forefront of this dynamic field. Spanning from 2010 to 2024, the journal offers an enriching platform for innovative ideas and practices, fostering collaboration among scholars and healthcare professionals alike. Although not open access, the content is meticulously curated to ensure high-quality scientific discourse, positioning the International Journal of Endocrinology and Metabolism as an essential reference for those dedicated to improving health outcomes related to endocrine and metabolic disorders.
JOURNAL OF ENDOCRINOLOGY
Advancing the Science of EndocrinologyJOURNAL OF ENDOCRINOLOGY, established in 1946 and published by BIOSCIENTIFICA LTD, stands as a premier scholarly outlet in the field of endocrinology, diabetes, and metabolism. With an impressive H-Index reflecting its significant contribution to the literature, this journal maintains a strong presence in academic circles, evidenced by its Q1 ranking in the 2023 Scopus categories for both Endocrinology and Diabetes and Metabolism. With its targeted scope serving a global audience of researchers, professionals, and students, it provides a vital platform for disseminating innovative research findings and advancing the scientific understanding of endocrine systems. As we approach its convergence year of 2024, JOURNAL OF ENDOCRINOLOGY remains committed to publishing high-quality, peer-reviewed articles that explore cutting-edge developments in the field, thereby impacting clinical practices and guiding future research directions.